Reduced anti-platelet therapy with pimecrolimus drug eluting stent (RAPID) A multi-center study of the pimecrolimus-eluting cobalt chromium coronary stent system (Corio) in patients with de novo lesions of the native coronary arteries

Trial Profile

Reduced anti-platelet therapy with pimecrolimus drug eluting stent (RAPID) A multi-center study of the pimecrolimus-eluting cobalt chromium coronary stent system (Corio) in patients with de novo lesions of the native coronary arteries

Discontinued
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2008

At a glance

  • Drugs Pimecrolimus (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms RAPID
  • Most Recent Events

    • 16 Oct 2008 Status changed from not yet recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 08 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top